The BioMedWire Podcast
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Daily cadence·114 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 14 epsHosts
Not detected.
Recent guests
Recent episodes
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
Jun 26, 2026
20m 49s
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis [Video Edition]
Jun 26, 2026
20m 49s
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
Jun 26, 2026
21m 10s
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology [Video Edition]
Jun 26, 2026
21m 10s
How Advanced Drug Delivery Could Improve Existing Cancer Treatments
Jun 5, 2026
21m 28s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/26/26 | multiple sclerosisdrug discovery+4 | — | Lucid-MSQuantum BioPharma Ltd.+4 | worldwide | multiple sclerosisLucid-MS+5 | — | 20m 49s | ||
| 6/26/26 | multiple sclerosisdrug discovery+3 | — | Lucid-MSQuantum BioPharma Ltd.+5 | worldwide | multiple sclerosisLucid-MS+5 | — | 20m 49s | ||
| 6/26/26 | DNA repair therapiesoncology+4 | — | ONC010(TM)PARP inhibitor+6 | — | DNA repaironcology+5 | — | 21m 10s | ||
| 6/26/26 | DNA Repair TherapiesOncology+4 | — | ONC010(TM)PARP inhibitor+5 | Canada | DNA Damage Response inhibitorscancer therapies+4 | — | 21m 10s | ||
| 6/5/26 | advanced drug deliverycancer treatments+4 | — | Sapu003Deciparticle(TM)+5 | — | drug deliverycancer therapy+5 | — | 21m 28s | ||
| 6/5/26 | advanced drug deliverycancer treatments+4 | — | Sapu003Deciparticle(TM)+5 | — | oncologydrug delivery+5 | — | 21m 28s | ||
| 6/2/26 | biopharmaceuticalsmultiple sclerosis+3 | Anthony Durkacz | Lucid-MSQuantum BioPharma Ltd.+3 | Austin, Texas | Quantum BioPharmaAnthony Durkacz+4 | — | 17m 20s | ||
| 6/2/26 | biopharmaceuticalsmultiple sclerosis+3 | Anthony Durkacz | Lucid-MSQuantum BioPharma Ltd.+3 | Austin, Texas | Quantum BioPharmamultiple sclerosis+3 | — | 17m 20s | ||
| 5/15/26 | CNS drug deliverybiotech market opportunities+4 | — | Oncotelic Therapeutics Inc.Biogen Inc.+3 | Alzheimer’s disease | CNSdrug delivery+5 | — | 19m 44s | ||
| 5/15/26 | CNS drug deliverybiotech market opportunities+3 | — | Oncotelic Therapeutics Inc.Biogen Inc.+3 | Alzheimer’s disease | CNSdrug delivery+5 | — | 19m 44s | ||
| 5/15/26 | GLP-1 receptor agonistsobesity treatment+3 | — | GEP-44SureNano Science Ltd.+5 | global | GLP-1obesity+5 | — | 22m 06s | ||
| 5/15/26 | GLP-1 receptor agonistsobesity treatment+3 | — | GEP-44SureNano Science Ltd.+6 | global | GLP-1obesity+3 | — | 22m 06s | ||
| 4/24/26 | biotechnologydrug pipelines+3 | — | Oncotelic Therapeutics Inc.GMP Bio+3 | — | biotechdrug commercialization+3 | — | 18m 32s | ||
| 4/24/26 | biotechnologydrug pipelines+3 | — | Oncotelic Therapeutics Inc.Sarepta Therapeutics Inc.+2 | — | biotechdrug commercialization+3 | — | 18m 32s |
Showing 14 of 14
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.